1BQM | A:1-429; B: | HIV-1 RT/HBY 097 |
1BQN | A:1-429; B: | TYR 188 LEU HIV-1 RT/HBY 097 |
1C0T | A:4-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+21.1326 |
1C0U | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+50.0934 |
1C1B | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GCA-186 |
1C1C | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-6123 |
1DLO | A:1-429; B: | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
1DTQ | A:4-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-1 (PETT131A94) |
1DTT | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2 (PETT130A94) |
1EET | A:1-429; B: | HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204 |
1EP4 | A:4-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH S-1153 |
1FK9 | A:4-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ) |
1FKO | A:1-429; B: | CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ) |
1FKP | A:1-429; B: | CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE |
1HAR | A: | 2.2 ANGSTROMS RESOLUTION STRUCTURE OF THE AMINO-TERMINAL HALF OF HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) |
1HMV | A:1-429; B:; C:1-429; D:; E:1-429; F:; G:1-429; H: | THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
1HNI | A:1-429; B: | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH THE NONNUCLEOSIDE INHIBITOR ALPHA-APA R 95845 AT 2.8 ANGSTROMS RESOLUTION |
1HNV | A:1-429; B: | STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS |
1HPZ | A:1-429; B: | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
1HQE | A:1-429; B: | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
1HQU | A:1-429; B: | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
1HVU | A:1-429; B:; D:1-429; E:; G:1-429; H:; J:1-429; K: | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT |
1HYS | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA |
1IKV | A:1-429; B: | K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFIVARENZ |
1IKW | A:1-429; B: | WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFAVIRENZ |
1IKX | A:1-429; B: | K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR PNU142721 |
1IKY | A:1-429; B: | HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC194 |
1J5O | A:1-429; B: | CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE-PRIMER |
1JKH | A:2-429; B: | CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ) |
1JLA | A:1-429; B: | CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651 |
1JLB | A:1-429; B: | CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE |
1JLC | A:1-429; B: | CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2 |
1JLE | A:1-429; B: | CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE |
1JLF | A:1-429; B: | CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE |
1JLG | A:2-429; B: | CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781 |
1JLQ | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 739W94 |
1KLM | A:2-429; B: | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152 |
1LW0 | A:4-429; B: | CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE |
1LW2 | A:1-429; B: | CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 1051U91 |
1LWC | A:4-429; B: | CRYSTAL STRUCTURE OF M184V MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE |
1LWE | A:1-429; B: | CRYSTAL STRUCTURE OF M41L/T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMN) IN COMPLEX WITH NEVIRAPINE |
1LWF | A:1-429; B: | CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMQ+M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITH NEVIRAPINE |
1N5Y | A:1-429; B: | HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P) |
1N6Q | A:1-429; B: | HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N) |
1QE1 | A:1-429; B: | CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE |
1R0A | A:1-429; B:1-429 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS |
1REV | A:4-429; B: | HIV-1 REVERSE TRANSCRIPTASE |
1RT1 | A:1-429; B:6-431 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC-442 |
1RT2 | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH TNK-651 |
1RT3 | A:2-429; B: | AZT DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 1051U91 |
1RT4 | A:1-429; B: | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC781 |
1RT5 | A:1-429; B: | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC10 |
1RT6 | A:1-429; B:6-431 | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC38 |
1RT7 | A:4-429; B:6-431 | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC84 |
1RTD | A:1-429; B:; C:1-429; D: | STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE |
1RTH | A:1-429; B:3-431 | HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES |
1RTI | A:1-429; B:5-431 | HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES |
1RTJ | A:1-429; B:2-431 | MECHANISM OF INHIBITION OF HIV-1 REVERSE TRANSCRIPTASE BY NON-NUCLEOSIDE INHIBITORS |
1S1T | A:3-429; B: | CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781 |
1S1U | A:4-429; B:5-428 | CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE |
1S1V | A:1-429; B:6-429 | CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651 |
1S1W | A:4-429; B:5-428 | CRYSTAL STRUCTURE OF V106A MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781 |
1S1X | A:2-429; B:6-428 | CRYSTAL STRUCTURE OF V108I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE |
1S6P | A:1-429; B: | CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943 |
1S6Q | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R147681 |
1S9E | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R129385 |
1S9G | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R120394. |
1SUQ | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R185545 |
1SV5 | A:1-429; B: | CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335 |
1T03 | A:1-429; B: | HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P) |
1T05 | A:1-429; B: | HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMER WITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMING NUCLEOTIDE SUBSTRATE |
1TKT | A:7-427; B:7-427 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW426318 |
1TKX | A:7-427; B:7-427 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW490745 |
1TKZ | A:7-427; B:7-427 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW429576 |
1TL1 | A:7-427; B:7-427 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW451211 |
1TL3 | A:7-427; B:7-427 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW450557 |
1TV6 | A:1-429; B:6-428 | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707 |
1TVR | A:1-429; B: | HIV-1 RT/9-CL TIBO |
1UWB | A:1-429; B: | TYR 181 CYS HIV-1 RT/8-CL TIBO |
1VRT | A:4-429; B: | HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES |
1VRU | A:3-429; B: | HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES |
2B5J | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165481 |
2B6A | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THR-50 |
2BAN | A:1-429 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R157208 |
2BE2 | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH R221239 |
2HMI | A:1-429; B: | HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX |
2HND | A:4-429; B: | CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE |
2HNY | A:4-429; B: | CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE |
2HNZ | B: | CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2 |
2I5J | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DHBNH, AN RNASE H INHIBITOR |
2IAJ | A:1-429; B: | CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH ATP |
2IC3 | A:1-429; B: | CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH NONNUCLEOSIDE INHIBITOR HBY 097 |
2RKI | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A TRIAZOLE DERIVED NNRTI |
2VG5 | B: | CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS |
2VG7 | B: | CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS |
2WON | A:1-429 | CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (WILD-TYPE). |
2ZD1 | A:-1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR |
2ZE2 | A:1-429; B: | CRYSTAL STRUCTURE OF L100I/K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR |
3BGR | A:-1-429; B: | CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR |
3DI6 | A:1-429; B: | HIV-1 RT WITH PYRIDAZINONE NON-NUCLEOSIDE INHIBITOR |
3DLK | A:3-429; B: | CRYSTAL STRUCTURE OF AN ENGINEERED FORM OF THE HIV-1 REVERSE TRANSCRIPTASE, RT69A |
3DM2 | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511. |
3DMJ | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 V106A AND Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511. |
3DOK | A:1-429; B: | CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW678248. |
3DOL | A:1-429; B: | CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW695634. |
3DRP | A:0-429; B: | HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR R8E |
3DRR | A:0-429; B: | HIV REVERSE TRANSCRIPTASE Y181C MUTANT IN COMPLEX WITH INHIBITOR R8E |
3DRS | A:0-429; B: | HIV REVERSE TRANSCRIPTASE K103N MUTANT IN COMPLEX WITH INHIBITOR R8D |
3E01 | A:1-429; B: | HIV-RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 2 |
3HVT | A:2-429; B: | STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE HETERODIMER |
3IRX | A:0-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE NON-NUCLEOSIDE RT INHIBITOR (E)-S-METHYL 5-(1-(3,7-DIMETHYL-2-OXO-2,3-DIHYDROBENZO[D]OXAZOL-5-YL)-5-(5-METHYL-1,3,4-OXADIAZOL-2-YL)PENT-1-ENYL)-2-METHOXY-3-METHYLBENZOTHIOATE. |
3IS9 | A:1-429; B: | CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE ALKENYLDIARYLMETHANE (ADAM) NON-NUCLEOSIDE RT INHIBITOR DIMETHYL 3,3'-(6-METHOXY-6-OXOHEX-1-ENE-1,1-DIYL)BIS(5-CYANO-6-METHOXYBENZOATE). |
3ISN | C:1-429; D: | CRYSTAL STRUCTURE OF HIV-1 RT BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR |
3ITH | A:1-429; B:; C:1-429; D: | CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR |
3KJV | A:1-429 | HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA |
3KK1 | A:1-429; B: | HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH NUCEOTIDE INHIBITOR GS-9148-DIPHOSPHATE BOUND IN NUCLEOTIDE SITE |
3KK2 | A:1-429; B: | HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH DATP BOUND IN THE NUCLEOTIDE BINDING SITE |
3KK3 | A:1-429; B: | HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH GS-9148 TERMINATED PRIMER |
3KLI | A:1-429; B: | CRYSTAL STRUCTURE OF UNLIGANDED AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE |
3LAK | A:1-429 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-HETEROCYCLE PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR |
3LAL | A:1-429 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-ETHYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR |
3LAM | A:1-429 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-PROPYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR |
3LAN | A:1-429 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-BUTYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR |
3LP0 | A:0-429; B: | HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR |
3LP1 | A:0-429; B: | HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR |
3LP2 | A:0-429; B: | HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR |
3M8P | A:1-429; B: | HIV-1 RT WITH NNRTI TMC-125 |
3M8Q | A:1-429; B: | HIV-1 RT WITH AMINOPYRIMIDINE NNRTI |
3NBP | A:1-429; B: | HIV-1 REVERSE TRANSCRIPTASE WITH AMINOPYRIMIDINE INHIBITOR 2 |
3QO9 | A:0-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TSAO-T, A NON-NUCLEOSIDE RT INHIBITOR (NNRTI) |
4DG1 | B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH POLYMORPHISM MUTATION K172A AND K173A |
4G1Q | A:-1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH RILPIVIRINE (TMC278, EDURANT), A NON-NUCLEOSIDE RT-INHIBITING DRUG |
4I2P | A:-1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) BASED ANALOGUE |
4I2Q | A:-1-429; B: | CRYSTAL STRUCTURE OF K103N/Y181C MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) ANALOGUE |
4KKO | A:-1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4-((4-METHOXY-6-(2-MORPHOLINOETHOXY)-1,3,5-TRIAZIN-2-YL)AMINO)-2-((3-METHYLBUT-2-EN-1-YL)OXY)BENZONITRILE (JLJ513), A NON-NUCLEOSIDE INHIBITOR |
4KO0 | A:-1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH AN ANILINYLPYRIMIDINE DERIVATIVE (JLJ-135) |
4LSL | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)-3-(3-(4-CHLORO-2-(2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)PHENYL)ACRYLONITRILE (JLJ476), A NON-NUCLEOSIDE INHIBITOR |
4MFB | A:4-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 8-(2-(2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY) INDOLIZINE-2-CARBONITRILE (JLJ555), A NON-NUCLEOSIDE INHIBITOR |